Evaluating the effects of daily microgreen powder supplementation over 60 days on fatigue and nutrition-related symptoms among women of reproductive age in Yangon, Myanmar

A waitlist-controlled trial evaluating the effects of daily supplementation with 10 g of microgreen powder over 60 days on malnutrition-related symptoms among women of reproductive age in Yangon, Myanmar

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14209798

Enrollment

204

Registered

2025-07-18

Start date

2025-08-20

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary micronutrient deficiency Nutritional, Metabolic, Endocrine

Interventions

Group A (intervention): Receives 10 g of microgreen powder daily, made from an equal blend of sunflower, mung bean and mustard seed, administered with water under nurse supervision at a community cent

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 03/10/2025: 1. Women aged 18-49 years 2. Resident of Yangon, Myanmar 3. Malnutrition Universal Screening Tool score indicating medium or high malnutrition risk 4. Not currently pregnant 5. Not taking any other nutritional supplements 6. Able and willing to provide informed consent _____ Previous inclusion criteria: 1. Women aged 18-49 years 2. Resident of Hlaing Tharyar township 3. Malnutrition Universal Screening Tool score indicating medium or high malnutrition risk 4. Not currently pregnant 5. Not taking any other nutritional supplements 6. Able and willing to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Low malnutrition risk score using the Malnutrition Universal Screening Tool 2. Severe acute/chronic illness or allergy to supplement ingredients 3. Having chronic diarrhoea for more than 2 weeks in the past 1-3 months or having known malabsorption disorders 4. Currently in another study or trial

Design outcomes

Primary

Measure	Time frame
1. Fatigue severity measured using the Fatigue Severity Scale (FSS) at baseline (T0) and day 60 (T1) 2. Body Mass Index (BMI) calculated from weight and height measurements using standard stadiometers and digital scales at baseline (T0) and day 60 (T1) 3. Malnutrition-related symptom severity measured using a structured Malnutrition Symptom Survey (Likert-scale) at baseline (T0) and day 60 (T1)	—

Secondary

Measure	Time frame
Acceptability and satisfaction with supplementation measured using a structured post-intervention questionnaire at day 60 (T1)	—

Countries

Myanmar

Contacts

Public ContactDaniel Israel Samuelsen

israel@edenmyanmar.org+95 (0)9694466755

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026